SCHEMBL29397104

SCHEMBL29397104

CSc1cc(Oc2ccnc3[nH]c(=O)cnc23)ccc1NC(N)=O

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937387 0.91 BRAF (0.69) BRAF
SCHEMBL29662245 0.87 BRAF (0.66) BRAF
SCHEMBL3751692 0.87 BRAF (0.66) BRAF
SCHEMBL2931666 0.83 BRAF (0.56) BRAF
Hydrochloric Acid SCHEMBL29394699 0.83 BRAF (0.56) BRAF
SCHEMBL29662257 0.82 BRAF (0.67) BRAF
SCHEMBL22919872 0.82 BRAF (0.67) BRAF
SCHEMBL28700856 0.82 BRAF (0.63) BRAF
SCHEMBL28933418 0.81 BRAF (0.66) BRAF
SCHEMBL2928470 0.81 BRAF (1.00) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114144410-A Polyarylurea derivatives and their use in the treatment of muscular diseases 阿纳格纳斯生物技术股份有限公司 2022-03-04 CN claimed
CN-114144410-A Polyarylurea derivatives and their use in the treatment of muscular diseases 阿纳格纳斯生物技术股份有限公司 2022-03-04 CN disclosed